Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Epidemiol Infect ; 139(4): 560-71, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20492746

RESUMEN

The purpose of this study was to determine the magnitude and distribution of acute gastrointestinal illness (GI) in the Chilean population, describe its burden and presentation, identify risk factors associated with GI and assess the differences between a 7-day, 15-day and a 30-day recall period in the population-based burden of illness study design. Face-to-face surveys were conducted on 6047 randomly selected residents in the Metropolitan region, Chile (average response rate 75·8%) in 2008. The age-adjusted monthly prevalence of GI was 9·2%. The 7-day recall period provided annual incidence rate estimates about 2·2 times those of the 30-day recall period. Age, occupation, healthcare system, sewer system, antibiotic use and cat ownership were all found to be significant predictors for being a case. This study expands on the discussion of recall bias in retrospective population studies and reports the first population-based burden and distribution of GI estimates in Chile.


Asunto(s)
Gastroenteritis/epidemiología , Población Urbana , Adolescente , Adulto , Anciano de 80 o más Años , Niño , Preescolar , Chile/epidemiología , Femenino , Gastroenteritis/patología , Humanos , Lactante , Recién Nacido , Entrevistas como Asunto , Masculino , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Adulto Joven
2.
J Pediatr ; 148(6): 747-52, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16769380

RESUMEN

OBJECTIVE: We analyzed postnatal growth in children with familial short stature (FSS) with regard to small (SGA) or appropriate (AGA) for gestational age status at birth. STUDY DESIGN: We studied 96 otherwise healthy short-statured children (58 males; SGA: n = 41, AGA: n = 55). At least one of the parents was short-statured. Cross-sectional data for length/height and weight for the first 4 years of age were collected retrospectively. RESULTS: AGA children had a mean length of 0.09 +/- 1.02 standard deviation score (SDS) at birth, -1.57 +/- 1.16 SDS after 1 year of age, and -2.36 +/- 0.72 SDS after 4 years. SGA children had a mean length of -2.04 +/- 1.06 SDS at birth, -2.70 +/- 1.12 SDS at 1 year of age, and -3.05+/-0.86 SDS at 4 years. The loss of length SDS within the first 2 years of life was greater in AGA than in SGA children. SGA children were significantly shorter than AGA children at all of the study points (p <.001). CONCLUSIONS: Children with an FSS background born AGA show catch-down growth to their lower familial range during the first 2 years of life. SGA children did not catch up to their AGA peers at any time.


Asunto(s)
Estatura , Desarrollo Infantil , Recién Nacido Pequeño para la Edad Gestacional , Padres , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Recién Nacido , Masculino
3.
J Pediatr ; 120(4 Pt 1): 599-604, 1992 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1552401

RESUMEN

To determine whether long-term renal sequelae follow the use of furosemide in preterm infants, we evaluated renal function in 27 former very low birth weight infants (less than 1500 gm) at 1 to 2 years of age. Patients were classified into three groups on the basis of status at the time of discharge from the hospital: group 1 (n = 7) had no furosemide treatment or renal calcifications, group 2 (n = 10) had furosemide therapy but no calcifications, and group 3 (n = 10) had furosemide therapy with renal calcifications. Renal ultrasonography at the time of the study demonstrated resolution of the calcifications in six patients in group 3. No differences in renal function were observed between groups 1 and 2. Creatinine clearance (mean +/- SEM) in group 3 (83.6 +/- 7.8 ml/min per 1.73 m2) was significantly lower than clearance in groups 1 and 2 (103.2 +/- 6.5 and 109.1 +/- 5.1, respectively; p less than 0.05). Children in group 3 had significantly higher urinary calcium/creatinine ratios and fractional excretion of sodium and lower tubular reabsorption of phosphate than children in the two other groups had. Urine-blood difference in carbon dioxide tension after oral acetazolamide load, which indicates the ability of the distal tubule to secrete hydrogen ions, was 8.4 +/- 3.4 mm Hg in group 3, significantly lower than values in groups 1 and 2 (22.6 +/- 3.1 and 28.0 +/- 4.3 mm Hg, respectively, p less than 0.05). Within group 3 the four children with persistent renal calcifications had significantly lower urine-blood carbon dioxide tension differences than did those with resolution of calcifications (p = 0.02). We conclude that furosemide-related renal calcifications in very low birth weight infants may lead to glomerular and tubular dysfunction; further long-term follow-up of this population is recommended.


Asunto(s)
Calcinosis/inducido químicamente , Furosemida/efectos adversos , Recién Nacido de Bajo Peso/fisiología , Enfermedades Renales/inducido químicamente , Enfermedades Renales/fisiopatología , Absorción , Calcinosis/complicaciones , Calcinosis/metabolismo , Calcio/orina , Dióxido de Carbono/sangre , Dióxido de Carbono/orina , Creatinina/orina , Femenino , Humanos , Lactante , Recién Nacido , Enfermedades Renales/complicaciones , Pruebas de Función Renal , Masculino , Nefrocalcinosis/complicaciones , Fosfatos/farmacocinética , Estudios Prospectivos , Sodio/orina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA